Imagine a world where young breast cancer survivors not only survive but thrive, reclaiming their lives with confidence and strength. That’s the promise of the YES System, a groundbreaking mobile health intervention that’s turning heads in the oncology community. But here’s where it gets controversial: can a smartphone app truly replace the human touch in cancer care? Let’s dive in.
Recent findings presented at the 2025 San Antonio Breast Cancer Symposium reveal that the Young, Empowered, and Strong (YES) program has significantly improved the quality of life (QOL) for adolescents and young adults (AYAs) battling breast cancer. After just six months, participants reported reduced symptoms and a better overall sense of well-being. And this is the part most people miss: the YES System doesn’t rely on constant clinician involvement, making it a potentially game-changing tool for busy, hard-to-reach patients.
In the YES clinical trial, 360 breast cancer survivors were divided into two groups: 179 used the YES app, while 181 received standard care. By the six-month mark, those using YES reported a Quality of Life in Adult Cancer Survivors (QLACS) general summary score of 77.6, compared to 78.1 in the control group. While the difference seems small, it’s the trend that’s remarkable: the YES group saw a 8.7-point drop in general QOL scores (indicating improvement), versus just a 1.6-point drop in the control group. Similarly, cancer-specific QOL scores improved by 7.8 points in the YES group, compared to 3 points in the usual care group. These numbers aren’t just statistics—they represent real lives transformed.
Dr. Ann H. Partridge, founder of the Program for Young Adults with Breast Cancer at Dana-Farber Cancer Institute, emphasizes the scalability of YES. “This intervention empowers patients to self-manage their symptoms and connect with their care team when needed,” she explains. “It’s a novel approach that could revolutionize survivorship care, especially for those who struggle to access traditional clinic visits.”
But is this the future of cancer care, or a risky shortcut? Critics might argue that digital tools can’t fully replace the empathy and expertise of a human clinician. Yet, for many young survivors juggling work, family, and treatment, the YES System offers a lifeline. Its features—monthly symptom tracking, AYA-specific concerns, a chat room, and a journal—are designed to foster independence while reducing feelings of isolation and stress.
The study included patients from Dana-Farber, The Ohio State University, and Columbia University Medical Center, with participants aged 15 to 39, diagnosed with stage 0 to 3 breast cancer. Most were White (80.6%), urban-dwelling (88.9%), and had stage 1 or 2 disease at diagnosis. The majority also underwent aggressive treatments like bilateral mastectomy and chemotherapy, highlighting the urgent need for supportive interventions during survivorship.
Dr. Partridge warns that untreated symptoms and concerns can lead to poor adherence to life-saving therapies and follow-up care, impacting not just QOL but also survival outcomes. “Serial monitoring through electronic patient-reported outcomes (ePROs) has already shown promise in adult cancer care,” she notes. “YES takes this a step further by putting the power directly in the patient’s hands.”
So, here’s the question: Can technology truly bridge the gap in cancer care, or does it risk dehumanizing an already challenging journey? Share your thoughts in the comments—we want to hear from you!
For more insights on innovative cancer care, subscribe to our newsletter and stay ahead of the curve in this rapidly evolving field.
